| dc.description.abstract | There is a two-way relationship between periodontal disease and diabetes. The purpose of this study was to evaluate the clinical and metabolic effects of a xanthan-based chlorhexidine (CHX) gel used as an adjunct to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis.Sixty-eight diabetic patients with moderate to advanced periodontitis and glycated hemoglobin (HbA1c) ?6% were selected. The test group (n = 34) received scaling and root planning (SRP) plus xanthan-based CHX gel. The control group (n = 34) received single SRP. Fasting blood sugar (FBS) and HbA1c tests were done at the baseline and after 3 and 6 months. Data from the study were analyzed using descriptive statistics (mean آ± standard deviation and frequency), ANOVA test by SPSS.15 software (SPSS Inc. Chicago, IL, USA). P < 0.05 was considered statistically significant.Patients in test group exhibited a decrease in FBS from the baseline (227 آ± 64.97) to the 3 and 6 months follow-up (208 آ± 61.95 and 201 آ± 61.33; P < 0.001). HbA1cb levels decreased from 7.72 آ± 0.99 to 6.20 آ± 0.97 and 6.06 آ± 1.04 after 3 and 6 months follow-up (P < 0.001), respectively. Reduction of FBS and HbA1c was statistically significant after 3 and 6 months in the control group (P < 0.001).Considering the limitations of this study, the application of CHX gel might improve the effects of nonsurgical periodontal treatment in diabetic patients with periodontitis. | |
